Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.125 USD | -1.44% | -0.29% | +37.10% |
May. 09 | Transcript : CorMedix Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.10% | 286M | |
+10.23% | 9.11B | |
-10.76% | 5.21B | |
+51.58% | 4.83B | |
+12.50% | 4.09B | |
-20.70% | 2.35B | |
+12.83% | 2.32B | |
+19.51% | 2.27B | |
-29.65% | 2.19B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix : B. Riley Lowers CorMedix' Price Target to $13.50 from $25 After FDA Rejects DefenCath Due to Manufacturing Issues, Keeps Buy Rating